Oxandrin oxandrolone oral anabolic steroid: Phase IV data; market

Preliminary data from an ongoing, open-label U.S. Phase IV trial of oxandrolone in 104 patients showed that 81% gained or maintained weight during the first 2 months (average 7-10 lbs), with changes g...